LATEST ALERTS
US alcohol bureau won’t approve CBD-infused drinks – at least for now
20th May 2019 - News analysis |
The US Alcohol and Tobacco Tax and Trade Bureau (ATTB) has said it will not approve the use of “hemp-CBD” in alcohol products
Regulation and legislation
CBD and cannabis news in brief: United States
20th May 2019 - News analysis , Regulatory alerts roundup |
The first in a new weekly round-up from around the US brings you news from Colorado, Florida, Indiana, Maine, New Jersey, New York, North Dakota, and Tennessee
CBD and cannabis news in brief: International
20th May 2019 - News analysis , Regulatory alerts roundup |
The first in a new weekly round-up from around the world brings you news from India, Canada – and the International Space Station
CBD and cannabis news in brief: Europe
20th May 2019 - News analysis , Regulatory alerts roundup |
The first in a new weekly round-up from around Europe brings you news from Belgium, Germany, Switzerland, the Netherlands, the Czech Republic, Lithuania and the EU
Tennessee brings ‘smoking hemp’ into its legal lexicon
17th May 2019 - News analysis |
The Tennessee legislature has enacted a bill which defines “smoking hemp”
Salvini’s bid to close down Italy’s CBD trade appears to be an empty threat
16th May 2019 - News analysis |
The Italian CBD market should not be severely curtailed despite deputy prime minister Matteo Salvini’s threat to destroy the legal cannabis industry
Michigan regulatory snapshot
15th May 2019 - Regulatory reports |
CBD products derived from industrial hemp are legal in the US state of Michigan, subject to certain conditions and regulations, which are explained in this CBD-Intel snapshot
Legal CBD firms face cash chaos as US Bank cancels their card accounts
14th May 2019 - News analysis |
Elavon Inc, a subsidiary of US Bank that processes card transactions, will cancel payment services for CBD businesses this week, documents seen by CBD-Intel reveal
Ohio regulatory snapshot
14th May 2019 - Regulatory reports |
Hemp is legal only for medical purposes under current Ohio state law, which makes no distinction between hemp and marijuana. But changes may be coming after the Senate passed a regulating bill
Some fear extracts ban as Germany beefs up constraints on CBD sales
14th May 2019 - News analysis |
Germany is tightening controls on CBD sales in a move that may lead to a ban on hemp extracts in Europe’s largest market and which has led some chain stores to remove products from shelves
Police seize ‘herbal’ stock in raid on ‘UK’s first cannabis restaurant’
13th May 2019 - News analysis |
Police have raided what is billed as the UK’s first cannabis restaurant, which features CBD products on its menu, seizing “a significant quantity of herbal cannabis”
Israeli and Chinese companies come to an understanding on cannabis
13th May 2019 - News analysis |
A new partnership expands Israel’s global cannabis ties and gives a Chinese investor access to an entire portfolio of cannabis and hemp-related start-ups
Belgium makes smokable flower rules clear – but tax plan raises fears
13th May 2019 - News analysis |
Regulations on the sale of smokable CBD flower products in Belgium have been clarified. But taxing the products like tobacco could send users to the black market, a campaign group has warned
New York State regulatory snapshot
13th May 2019 - Regulatory reports |
Our first regulatory snapshot on New York State explains the legal status of CBD and CBD products, hemp and hemp extracts, and the rules governing their cultivation, processing, import and export
New Zealand’s recreational cannabis referendum won’t affect CBD
9th May 2019 - News analysis |
A decision on legalising recreational cannabis in New Zealand will go to a referendum to be held next year, but the outcome is not likely to affect the regulatory status of CBD
CBD stakeholders join the parade at grand Paris cannabis festival
8th May 2019 - News analysis |
Participants at the Paris 420 Festival, organised by NORML France (National Organisation for the Reform of Marijuana Laws), were keen to raise public awareness of hemp’s various properties
Turkey regulatory snapshot
7th May 2019 - Regulatory reports |
While the regulations governing CBD are extremely harsh, the Turkish government recently announced the launch of hemp cultivation for industrial use on a large scale
California regulatory snapshot
7th May 2019 - Regulatory reports |
The sale of CBD, hemp extracts and flowers is legal in California, subject to a minimal regulatory burden, which CBD-Intel explains in detail in our first US state regulatory snapshot
CBD in South Africa: regulatory snapshot
2nd May 2019 - Regulatory reports |
Cannabis and CBD are controlled substances in South Africa. Our snapshot gives you the details of what may be allowed and what is not
Importer beware: uncertainties persist in Hong Kong regulations
29th April 2019 - Regulatory reports |
While no product-specific regulation covers CBD products in Hong Kong, this report examines the rules that apply to their import, export, production and sale in the territory
Will FDA draw a line between other CBD products and pharmaceuticals?
29th April 2019 - News analysis |
The US FDA is to hold a public hearing on 31st May on the safety of products containing cannabis or cannabis-derived compounds ― and stakeholders will be looking for a dividing line
When will CBD foods be legal in the US? Don’t hold your breath
25th April 2019 - News analysis |
Could CBD soon be legally sold as a dietary supplement or food in the US? The answer depends on how quickly the federal regulatory framework on cannabis in general and CBD in particular can be eased
Hemp growing on the rise, but Ireland still sends abroad for medical supplies
25th April 2019 - News analysis |
Ireland’s Department of Health still won’t commit to allowing farmers to grow cannabis for medical use, two years after the health minister announced a medical cannabis access programme
Brits back CBD for health; hemp seeds can be imported in US; German raids
23rd April 2019 - News analysis |
CBD-Intel News in Brief from the UK, US and Germany
New regulation kick-starts CBD and cannabis industry in Peru
19th April 2019 - News analysis |
As a potential CBD and cannabis market emerges in Peru, players from across the globe are seeing a valuable opportunity for investing in the country
Mexican legalisation may come with added regulation and controls
18th April 2019 - News analysis |
Mexico is well on its way to fully legalising cannabis and its derivative products, but the new government may impose stricter regulation than that left by the previous regime
Big Pharma ‘must not be allowed to set EU legal agenda on medical cannabis’
17th April 2019 - News analysis |
Europe desperately needs harmonised legislation on medical cannabis – but it could take five years, and Big Pharma must not be allowed to set the agenda, delegates at a conference in Brussels heard
CBD not a controlled substance: Ireland regulatory report
17th April 2019 - Regulatory reports |
CBD-Intel provides detail on the regulations governing CBD in Ireland, where cannabis, THC and CBN (cannabinol) are controlled substances
US attorney general favours bid to let states decide cannabis and CBD policy
16th April 2019 - News analysis |
US attorney general William Barr has said the current patchwork regulatory situation for CBD in the country is “intolerable” and given qualified support to an act which would allow states to decide their own policies
Spain clears up the confusion by clamping down on CBD novel foods
11th April 2019 - News analysis |
The Spanish Agency for Consumption, Food Safety and Nutrition (AECOSAN) has issued a notice on hemp and cannabinoid use in foods, clarifying its position on European novel food regulations
European Commission differentiates CBD as cosmetic ingredient
10th April 2019 - News analysis |
CBD’s entry in the European Commission’s database of cosmetics ingredients has been expanded to differentiate it from generic cannabis and by-products. The move offers more, but not total, clarity
Swedish firms rein in dietary sales and health claims until courts decide
9th April 2019 - News analysis |
Several Swedish companies offering dietary supplements with CBD oil produced from industrial hemp have either stopped selling the products or significantly toned down promises of its health benefits
Questions in UK parliament after medical cannabis is seized at airport
9th April 2019 - News analysis |
Just two out of around 80 people prescribed medical cannabis in the UK have received products containing THC, with the rest getting CBD, the British parliament has heard
Federal assistance proposed for US CBD businesses with banking issues
5th April 2019 - News analysis |
Proposed new federal legislation in the US could finally help CBD businesses gain easier access to banking, a problem that has bedevilled legal cannabis-related industries since their inception.
US Postal Service offers guidance on mail delivery of CBD products
4th April 2019 - News analysis |
Use of the federal mail to deliver CBD products has remained a vexed question for companies in the US since the passing of the 2018 Farm Bill. Now the US Postal Service has shone some light on the issue
FDA wades in with guidance on CBD – and warnings over ‘deceptive’ claims
3rd April 2019 - News analysis |
A high-level working group will explore legal pathways to market for certain CBD products, according to the US FDA – which also revealed it had sent warning letters to three companies it accused of “unfounded claims”
Ohio Senate passes bill to establish CBD market, as Texas delists hemp
3rd April 2019 - News analysis |
Ohio is moving a step nearer following its neighbour Michigan in distinguishing hemp-derived CBD products from state cannabis regulations, while Texas is to remove hemp from its list of controlled substances
EU agriculture committee approves proposal to raise THC limit to 0.3%
3rd April 2019 - News analysis |
The European Parliament’s agriculture committee has approved proposals to put forward an amendment to the Common Agriculture Policy allowing hemp farmers to grow varieties with as much as 0.3% THC
Mile High accuses rival CBD firm of copyright infringement and deceit
1st April 2019 - News analysis |
Investments made by Turning Point Brands in a CBD extraction company were based on misleading information, a lawsuit filed in a US court alleges
Mexican regulatory body repeals guidelines amid confusion
29th March 2019 - News analysis |
The Mexican Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) has changed its mind over the regulatory framework established for cannabis products in late 2018
Philippines moves one step closer to legalising medical cannabis
29th March 2019 - News analysis |
The Philippines moved one step closer to legalising cannabis for medical use when a bill was approved on its final reading, but its progress to law could be scuppered by opposition from president Rodrigo Duterte.
Leading UK specialist calls for medical cannabis trials – NICE says yes
28th March 2019 - News analysis |
The UK’s National Institute for Health and Care Excellence (NICE) promises trials of medical cannabis after a senior consultant told a parliamentary committee of his worries about it being widely prescribed
Cannabis troubles – UK committee hears of inconsistency and confusion
26th March 2019 - News analysis |
Inconsistent quality of products purchased online, and confusion over cannabis itself, could be putting patients at risk, a group of UK MPs were told during presentations on medical cannabis and related issues
Cannabis is popular left, right and centre as Israeli election approaches
22nd March 2019 - News analysis |
Politicians in Israel are rarely united on any single issue, but as the much contended Israeli election draws nearer, members from across the political spectrum support the full legalisation of recreational cannabis
Contrary to reports, the UK CTA is not suing EU over novel food rules
20th March 2019 - News analysis |
Lawyers for the UK Cannabis Trades Association (CTA) have confirmed to CBD-Intel that they have not been instructed to sue the EU over novel food guidance for cannabinoids including CBD – contrary to reports
Swiss company plans final appeal against 25% tax on cannabis flowers
19th March 2019 - News analysis |
An appeal is planned against a Swiss court’s decision that low-THC cannabis flowers should continue to be taxed at the same 25% rate as fine-cut tobacco – a decision that came as no surprise to most Swiss CBD companies
There’s room yet for growth and untangling in Canada’s legal reform
18th March 2019 - News analysis |
Nearly five months after Canada legalised cannabis, its fledgling system for delivering cannabis and CBD products to consumers is still experiencing growing pains
Will European authorities change their view of cannabinoids?
15th March 2019 - News analysis |
Lobbyists have highlighted flaws in European authorities’ current classification of cannabinoids as novel foods which could signal change
CBD still in grey area but optimism for future: Israel regulatory report
15th March 2019 - Regulatory reports |
Our latest regulatory report on CBD in Israel covers the hemp plant’s status, the import and export of finished product and much more.
Cannabis is a dangerous drug under Israeli criminal law; the possibility of legalising industrial hemp is presently being explored by the government. The legality of CBD products imported and distributed in Israel remains a grey area; the Ministry of Health considers CBD a dangerous drug while the police have declared it legal – while also decriminalising cannabis…
Status and future of CBD oil in Sweden is in the lap of the courts
12th March 2019 - News analysis |
The future of CBD oil in Sweden is about to be decided as several cases inch their way through the country’s administrative courts
